The Phase 3 TRIUMPH-4 trial (NCT05869903) enrolled adults with obesity and knee osteoarthritis
The NHS symptoms list groups them into general anaemia symptoms (tiredness, breathlessness, headaches, loss of appetite, weight loss) and neurological signs (peripheral neuropathy, balance problems, depression, memory and concentration changes, sometimes mood changes or psychosis in advanced cases)
NAD+ therapy (injections/IVs) excels, boosting levels, mitochondrial function, and energy.[20][21] Clinical evidence shows improvements in fatigue and metabolic markers, with some studies reporting enhanced quality of life
VEGFR2 may be involved in endothelial cell development, proliferation, and lifespan (5)
Retrieved from RxList
These materials are not for human consumption and are not intended for medical, veterinary, diagnostic, or household use of any kind